GlobeNewswire

Mesa Labs Announces First Quarter Results
10/08/2026
LAKEWOOD, Colo., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality control [...]
Olema Oncology Reports Second Quarter 2026 Financial and Operating Results
10/08/2026
Completed enrollment in the pivotal Phase 3 OPERA-01 trial; top-line data are now expected in the first quarter of 2027 Presented initial Phase 1 clinical data for OP-3136 at the 2026 ASCO Annual Meeting Announced a [...]
HRC Technology Solutions LLC Achieves SOC 1 Type 2 and SOC 2 Type 2 Compliance, Reinforcing Secure, AI-Driven Revenue Cycle Management
10/08/2026
SOUTHLAKE, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- HRC Technology Solutions LLC today announced it has achieved SOC 1 Type 2 and SOC 2 Type 2 compliance, independently assessed by ControlCase as its Qualified Security [...]
MAPS Responds to Report of Progress for MDMA-assisted therapy for PTSD with FDA
10/08/2026
The reported resubmission of the New Drug Application will initiate a new evaluation of the treatment’s safety and efficacy for potential FDA approval Recently updated FDA guidance, Psychedelic Drugs: Considerations for [...]
Dallas Hair Replacement for Business Professionals Offers Non-Surgical Hair Replacement for Men
10/08/2026
Look Sharp, Stay Competitive. Restore your confidence with non-surgical hair replacement in Dallas. Dallas, TX, Aug. 10, 2026 (GLOBE NEWSWIRE) -- In the competitive business environment of Dallas, confidence and success [...]
Interpace Biosciences Announces Second Quarter 2026 Financial and Business Results
10/08/2026
Q2 Revenue of $9.1 million Q2 Income from Continuing Operations of $0.3 million Q2 Thyroid volume year-over-year increase of 6% Q2 Thyroid revenue year-over-year increase of 9% Trailing twelve-month thyroid revenue of $ [...]
Essential Amino Acid Intake Draws Focus During GLP-1 Therapy as Oh!mino Targets Muscle Loss
10/08/2026
Seal Beach, CA, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Oh!Nutrition, a California-based nutritional product development company, today announced Oh!mino® Muscle Synthesis Activator, an essential amino acid supplement [...]
SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update
10/08/2026
Initiated a Phase 1 study of SCY-770, a first-in-class, potent and direct AMPK activator for treatment of ADPKD; topline data are expected in Q3 2026 and are anticipated to inform dose selection for the planned Phase 2 [...]
Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights
10/08/2026
Enrollment continues across all indications in Ntrust-1 and Ntrust-2 at the 4 billion cell dose level (12 billion cells in 3-dose cycle) Initial clinical data from Ntrust-1 and Ntrust-2 expected to be presented at a [...]
Palisade Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of PALI-2108 Into Phase 2 Development
10/08/2026
Advancing a potentially best-in-class once-daily oral, locally-activated PDE4 inhibitor prodrug specifically engineered for the treatment of inflammatory bowel disease (IBD) Enrollment of first patient for Phase 2 [...]
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
10/08/2026
The BACKBEAT global pivotal trial (“BACKBEAT Trial”), conducted in collaboration with Medtronic, is on track to reach its target of 284 evaluable randomized patients by end of Q3 2026, with primary data presentation [...]
Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
10/08/2026
Antwerp, Belgium, August 10, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab” or the “Company”), a clinical-stage biopharmaceutical company focused on fibro-inflammatory diseases, today announced that its Board of [...]
Sana Biotechnology Reports Second Quarter 2026 Financial Results and Business Updates
10/08/2026
Continued progress toward starting SC451 Phase 1/2 trial, including GLP toxicology studies, SC451 process transfer to the contract manufacturer, and clinical trial readiness Continued progress toward starting clinical [...]
Women's Health Collective Canada and GreenShield Launch Partnership to Advance Midlife Women's Health Research and Support
10/08/2026
National partnership will help generate critical evidence and improve awareness, education, and support for women navigating the menopause transition and beyond in Canada TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Women [...]
L’Association canadienne pour l’équité en santé des femmes et GreenShield lancent un partenariat en faveur de la recherche et du soutien dans le domaine de la santé des femmes dans la cinquantaine
10/08/2026
Ce partenariat national aidera à produire des données probantes et à améliorer les ressources de sensibilisation, d’éducation et de soutien pour les femmes vivant la transition vers la ménopause au Canada TORONTO, 10 [...]
Compass Health to purchase Friday Harbor facility from San Juan County, supporting behavioral health care in the islands long-term
10/08/2026
State funding and a decades-long county partnership secure the building's future FRIDAY HARBOR, Wash., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Compass Health is purchasing its Friday Harbor facility located at 520 Spring [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2026
10/08/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 04th August to 05th August 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 32 - 2026
10/08/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 4 août au 5 août 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston
10/08/2026
CEO Michael Halstead to participate in a fireside chat on Wednesday, August 12 at 12:00 p.m. EDT NEW YORK and TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “ [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum